Sunday, July 31, 2011 9:59:51 AM
dianne; the only reason neph is even still trading is because in this one instance the owners of neph also manage and control a hedge fund (ie wall street is on both sides of this battle).
if this was not the case neph would be sub penny and virtually worthless at this point.
thus the owners of neph and wex/lambda cant sell their position in the company until the make the warrants exercisable as well. At this point almost half their position in neph is warrants (this increased their ownership from 42% to 73%).
Bottom line, as long as we exit when they do we will be more than "just fine" and it would be illegal for them to dump their position without opening the exercising of warrants to the shareholders.
if this was not the case neph would be sub penny and virtually worthless at this point.
thus the owners of neph and wex/lambda cant sell their position in the company until the make the warrants exercisable as well. At this point almost half their position in neph is warrants (this increased their ownership from 42% to 73%).
Bottom line, as long as we exit when they do we will be more than "just fine" and it would be illegal for them to dump their position without opening the exercising of warrants to the shareholders.
Recent NEPH News
- Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise • GlobeNewswire Inc. • 04/01/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:00:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:54:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:53:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:17:19 PM
- Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 08:10:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:01:16 PM
- Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 03/05/2026 12:04:28 PM
- Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors • GlobeNewswire Inc. • 02/13/2026 01:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:15:32 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2025 11:15:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2025 10:00:38 PM
- Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History • GlobeNewswire Inc. • 11/06/2025 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:01:11 PM
- ¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 10/30/2025 08:00:00 PM
- Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water • GlobeNewswire Inc. • 10/08/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2025 08:09:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:15:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2025 08:39:24 PM
- Nephros Announces Strong Second Quarter Financial Results • GlobeNewswire Inc. • 08/07/2025 08:00:00 PM
- Nephros Schedules Second Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 07/31/2025 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 08:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:15:47 PM
